Evidence map›Paper›PMID 40568026›Full record

ArticleMolecular therapy. Nucleic acids2025

Restoration of myogenesis in ALS-myocytes through miR-26a-5p-mediated Smad4 inhibition and its impact on motor neuron development.

Caterina Peggion, Raphael Severino Bonadio, Roberto Stella, Silvia Scalabrin, Laura Pasetto, Caterina Millino, Laura Camporeale, Beniamina Pacchioni, Valentina Bonetto, Alessandro Bertoli and 2 more

Abstract read
In one paragraph

Article in Molecular therapy. Nucleic acids, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Caterina PeggionDepartment of Biology, University of Padova, 35131 Padova, Italy.
Raphael Severino BonadioDepartment of Biology, University of Padova, 35131 Padova, Italy.
Roberto StellaDepartment of Chemistry, Istituto Zooprofilattico Sperimentale delle Venezie, 35020 Legnaro, Padova, Italy.
Silvia ScalabrinDepartment of Biology, University of Padova, 35131 Padova, Italy.
Laura PasettoResearch Center for ALS, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy.
Caterina MillinoDepartment of Biology, University of Padova, 35131 Padova, Italy.
Laura CamporealeResearch Center for ALS, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy.
Beniamina PacchioniDepartment of Biology, University of Padova, 35131 Padova, Italy.
Valentina BonettoResearch Center for ALS, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy.
Alessandro BertoliDepartment of Biomedical Sciences, University of Padova, 35131 Padova, Italy.
Stefano CagninDepartment of Biology, University of Padova, 35131 Padova, Italy.
Maria Lina MassiminoNeuroscience Institute, Section of Padova, National Research Council (CNR), 35131 Padova, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amyotrophic lateral sclerosis (ALS) is the most common adult-onset paralytic disorder, characterized primarily by a progressive loss of motor neurons (MNs) in which degeneration skeletal muscle involvement has been demonstrated. Skeletal muscle is a plastic tissue that responds to insults through proliferation and differentiation of satellite cells. Skeletal muscle degeneration and regeneration are finely regulated by signals that regulate satellite cell proliferation and differentiation. It is known that satellite cell differentiation is impaired in ALS, but little is known about the involvement of microRNAs (miRNAs) and their role in intercellular communication in ALS. Here we demonstrated impaired differentiation of satellite cells derived from ALS mice related to the impairment of myogenic p38MAPK and protein kinase A (PKA)/pCREB signaling pathways that can be regulated by miR-882 and -134-5p. These miRNAs participate in autocrine signaling in association with miR-26a-5p that, secreted from wild-type (WT) and captured by ALS myoblasts, enhances ALS-related myoblast differentiation by repressing Smad4-related signals. Moreover, miR-26a-5p and -431-5p work in a paracrine way ameliorating motoneuron differentiation. These findings emphasize the need to better understand intercellular communication and its role in ALS pathogenesis and progression. They also suggest that miRNAs could be targeted or used as therapeutic agents for myofiber and MN regeneration.

Indexed as

amyotrophic lateral sclerosiscell communicationmiRNAMT: non-coding RNAsmyogenesisneurogenesisneuromuscular disordersprimary stem cellsskeletal muscle

Identifiers

PMID40568026
PMCPMC12191306

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.